Published Online: Tuesday, July 1, 2008

The Maine Benzodiazepine Study Group is seeking pharmacists' input to determine how many take-back and disposal drug programs are in the United States. Currently, no consolidated list of these programs exists across the country and abroad. The goal is that the survey will be updated annually.

The results will be published in the National Directory for Drug Take-Back and Disposal Programs. The findings will be presented at the November 2008 International Symposium on Pharmaceuticals in the Home and Environment: Catalysts for Change.

The survey is spearheaded by the Maine group, but will be conducted by the Community Medical Foundation for Patient Safety in Bellaire, Texas. To take the survey, visit

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues